Custom Antibody Market Overview and Growth by 2028
Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028Custom Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Service (Antibody Development, Antibody Production and Purification, and Antibody Fragmentation and Labelling), Type (Monoclonal Antibodies, Polyclonal Antibodies, and Other Custom Antibodies), Source (Mice, Rabbits, and Others), and Research Area (Oncology, Immunology, Stem cells, Infectious Diseases, Neurobiology, Cardiovascular Diseases, and Others), End Users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organizations), and Geography
- Report Date : Jun 2021
- Report Code : TIPRE00004474
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 216
The custom antibody market was valued at US$ 833.71 million by 2028 from US$ 409.26 million in 2021; it is estimated to grow at a CAGR of 10.7% from 2021 to 2028.
Customized antibodies can be generated in a mouse, rat, or hamster, to meet any host requirements. Companies are providing wide range of antibodies according to the researcher's requirements. There are variety of customized antibodies in the market which includes polyclonal and monoclonal antibody, recombinant monoclonal antibody, hybridoma antibody, polyclonal recombinant antibody, and others. Companies are offering complete support services for all types and steps of antibody production from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification.
The growth of the custom antibody market is attributed to the factors such as the high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology. However, the production for the monoclonal and polyclonal antibodies varies based on the animals being used to derive them. The cost is also determined by the packages of custom antibodies demanded for different applications that are offered by different players hinders the market growth.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Custom Antibody Market: Strategic Insights
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Custom Antibody Market: Strategic Insights
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Market Insights
Production and Development Services Offered by Custom Antibody Providers
Various companies are aggressively offering research and development services for custom antibodies. A few of such services launched in by these companies are mentioned below.
- In June 2021, GenScript announced the launch of its MonoRab, a custom rabbit monoclonal antibody (mAB) service. It is added in company’s integrated premium antibody service portfolio. MonoRab is the company’s proprietary technology that utilizes the combination of hybridoma technologies and early-stage monoclonal antibody sequencing. Both technologies delivers custom rabbit mAbs that are more specific and possess higher affinity as well as diversified abilities required for a broad range of applications.
- In March 2021, Giotto Biotech launched specialized polyclonal and monoclonal antibody production services. The company facilitates the production of more than 500 monoclonal antibody types that can be used for diagnostic and therapeutic applications. It offers a large choice of species as the sources of polyclonal antibodies.
- In November 2020, AMSBIO announced development services for rabbit and mouse recombinant monoclonal antibodies. The development of recombinant monoclonal antibodies is based on the DimAb development platform, which is different from conventional hybridoma fusion technologies. It has ability to isolate IgG genes from B cells of immunized animals. These antibodies assist in the development and commercialization of drugs in the market. In October 2019, the FDA approved first rabbit monoclonal antibody-derived drug—Beovu. Beovu is intended to treat wet age-related macular degeneration (AMD).
- In March 2020, Absolute Antibody Ltd announced the launch of high-throughput recombinant antibody production service for its FleXpress. The company offers its customers with services for facilitating the rapid expression of many antibodies, up to a volume of 80 ml scale, as well as for propelling the production capacity to meet rising demands for recombinant antibody technology.
Such custom antibody production services offered by companies are accelerating the market growth.
Service - Based Insights
Based on service, the custom antibody market is segmented into antibody development, antibody production and purification, and antibody fragmentation and labelling. In 2020, the antibody development segment held the largest share of the market, and is estimated to grow at significant CAGR during the forecast period.
Type-based Insights
Based on type, the custom antibody market is segmented into monoclonal antibodies, polyclonal antibodies, and other custom antibodies. In 2020, the monoclonal antibodies segment held the largest share of the market, whereas the polyclonal antibodies segment is expected to grow during the forecast period.
Source -based Insights
Based on source, the custom antibody market is segmented into mice, rabbit, and others. The mice segment held the largest share of the market in 2020, whereas the mice segment is anticipated to register the highest CAGR in the market during the forecast period.
Research Area -based Insights
Based on research area, the custom antibody market is segmented into oncology, immunology, stem cells, infectious disease, neurobiology, cardiovascular disease, and others. The oncology segment held the largest share of the market in 2020, whereas the stem cells segment is anticipated to register the highest CAGR in the market during the forecast period.
End Users-based Insights
Based on end users, the custom antibody market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations. In 2020, the pharmaceutical and biotechnology companies segment held the largest share of the market and is expected to grow at the fastest rate during the coming years.
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the breast reconstruction market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.
Custom Antibody Market Regional Insights
The regional trends and factors influencing the Custom Antibody Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Custom Antibody Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
- Get the Regional Specific Data for Custom Antibody Market
Custom Antibody Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 409.26 Million |
| Market Size by 2028 | US$ 833.71 Million |
| Global CAGR (2021 - 2028) | 10.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Service
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Custom Antibody Market Players Density: Understanding Its Impact on Business Dynamics
The Custom Antibody Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Custom Antibody Market are:
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Custom Antibody Market top key players overview
By service
- Antibody Development
- Antibody Production and Purification
- Antibody Fragmentation and Labelling
By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Other Custom Antibodies
By Source
- Mice
- Rabbits
- Others
By Research Area
- Oncology
- Immunology
- Stem Cells
- Infectious Diseases
- Neurobiology
- Cardiovascular Diseases
- Others
By End Users
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Cell Signaling Technology, Inc
Frequently Asked Questions
What is the regional analysis in terms of custom antibody market?
The growth of the region is attributed to factors such as rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in Asia Pacific. In addition, the Europe is expected account for the fastest growth in the custom antibody market. A high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology growth of Europe custom antibody market during the forecast period.
What is Custom Antibody mean?
Customized antibodies can be generated in a mouse, rat or hamster, to meet any particular host requirements. Companies are providing wide range of antibodies according to the researcher's requirements. There are variety of customized antibodies in the market which includes polyclonal and monoclonal antibody, recombinant monoclonal antibody, hybridoma antibody, polyclonal recombinant antibody and others. Companies are offering complete support services for all types and steps of antibody production from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification.
What are the driving factors for the custom antibody market across the globe?
The growth of the market is attributed to some key driving factors such as the high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology. For instance, In January 2021, Morphic Therapeutic, a biotechnology company, collaborated with Janssen Pharmaceutical, Inc., a part of Johnson & Johnson Private Limited, to develop novel antibodies against third integrin target proteins (a family of ubiquitous receptors. Such strategic steps are also projected to drive the market growth.
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
The List of Companies - Custom Antibody Market
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Cell Signaling Technology, Inc
Get Free Sample For